A study presented at the 2021 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium found that a novel patient-focused, artificial intelligence (AI)–driven clinical trial support tool can aid in providing patients access to clinical trials.
The novel search tool, which can be found at www.ancora.ai, uses AI to restructure trial information. By democratizing trial information, investigators suggested that trial accrual as well as patient satisfaction will increase as disparities decrease simultaneously.
In an interview with CancerNetwork®, Pashtoon Murtaza Kasi, MD, MSc, of the University of Iowa, explained what such a platform could afford both oncologic providers and patients.
Transcription:
You know, I think the same problem that patients and caregivers face, [providers]…seem to face the same issue every day. The nice thing about some of these trials is…
